Pure Bioscience unveiled Pure Control, an antimicrobial processing aid designed for use in poultry processing facilities. The product has received approval from the U.S. Food and Drug Administration (FDA), and is awaiting further approval from the USDA.
The company introduced the new antimicrobial product at a special event held January 27 in conjunction with the International Production and Processing Expo (IPPE) in Atlanta, Georgia.
Pure Control has been developed as an antimicrobial poultry processing aid for direct application to poultry carcasses, parts and organs to reduce pathogen populations. According to Hank Lambert, CEO of Pure Bioscience, Pure Control maximizes microbial control and is highly effective against Salmonella, Listeria, E. Coli and many other pathogens.
“We believe Pure Control will be an important breakthrough to help make poultry safer for consumers, as raw poultry processors combat prevalent and persistent contaminants,” stated Hank Lambert, CEO of Pure Bioscience. “Attaining FDA approval as a direct food contact processing aid for poultry is a huge milestone for Pure. It marks the first food contact FDA approval for our patented SDC antimicrobial technology. We have also received FDA approval for use as a produce processing aid.”
The final step in the regulatory approval process for commercialization of SDC-based Pure Control for poultry is to obtain USDA approval. The approval process will involve plant trials with the USDA and are expected to take 45-60 days.
Pure Control, along with Pure Hard Surface, is designed to provide a complete solution in controlling Salmonella and other pathogens in Poultry Processing Facilities. Together, the products provide enhanced cross-contamination protection directly on poultry for processing and on food contact surfaces in the processing facility.
“Pure Bioscience is positioned with a complete solution to make the U.S. food supply safer, addressing the foodborne illness issues that have plagued processors and high-profile retail and restaurant chains,” the company stated in a press release.
See all the latest IPPE news.
